Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
McGill University
$120,000.00
From Molecular Markers to Neural Oscillations: Bridging Dopamine and Brain Rhythms in Schizophrenia
FY 2025-26
Summary
Schizophrenia is a serious, chronic mental illness that usually begins in young adulthood. Medications for schizophrenia work by their impact on dopamine, a chemical that has long been linked to the illness; however, these drugs often cause difficult side effects. To improve the quality of life in these individuals, we need new targets connected to dopamine that can be safer and more precise. My proposed project focuses on both dopamine and brain activity. In schizophrenia, one specific type of brain activity, called beta rhythms, has been seen to be different compared to those without the illness. This is important because easy-to-administer brain stimulation techniques, such as magnetic or electrical stimulation, can change these rhythms, which is already being done in other diseases that have dopamine changes. To link dopamine and beta rhythms, I will use two brain imaging methods, including one called neuromelanin-MRI. Neuromelanin is found in the brain cells that produce dopamine, so it can be used as a measure of dopamine. This technique is quick and does not require injections, making it accessible for clinical populations. My previous work has shown that people with schizophrenia have higher neuromelanin signal, and other studies show that they also have abnormal beta rhythms. However, no studies have shown how these two features are related. In this project, I will merge neuromelanin-MRI and brain activity imaging in those with and without schizophrenia. I will test whether higher neuromelanin signal is linked to more changes in beta rhythms, and whether this connection is related to more severe symptoms. By identifying how dopamine changes disrupts beta rhythms, this research could pave the way for new treatments that safely restore normal brain activity in schizophrenia.
Department
Program
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
560186
Name
Ahrens Jessica
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
DT2 (Health services and population health research) CGRS Doctoral
Projecttitle
From Molecular Markers to Neural Oscillations: Bridging Dopamine and Brain Rhythms in Schizophrenia
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Dopamine; Neural Oscillations; Neuroimaging; Psychosis; Schizophrenia
Abstract
Schizophrenia is a serious, chronic mental illness that usually begins in young adulthood. Medications for schizophrenia work by their impact on dopamine, a chemical that has long been linked to the illness; however, these drugs often cause difficult side effects. To improve the quality of life in these individuals, we need new targets connected to dopamine that can be safer and more precise. My proposed project focuses on both dopamine and brain activity. In schizophrenia, one specific type of brain activity, called beta rhythms, has been seen to be different compared to those without the illness. This is important because easy-to-administer brain stimulation techniques, such as magnetic or electrical stimulation, can change these rhythms, which is already being done in other diseases that have dopamine changes. To link dopamine and beta rhythms, I will use two brain imaging methods, including one called neuromelanin-MRI. Neuromelanin is found in the brain cells that produce dopamine, so it can be used as a measure of dopamine. This technique is quick and does not require injections, making it accessible for clinical populations. My previous work has shown that people with schizophrenia have higher neuromelanin signal, and other studies show that they also have abnormal beta rhythms. However, no studies have shown how these two features are related. In this project, I will merge neuromelanin-MRI and brain activity imaging in those with and without schizophrenia. I will test whether higher neuromelanin signal is linked to more changes in beta rhythms, and whether this connection is related to more severe symptoms. By identifying how dopamine changes disrupts beta rhythms, this research could pave the way for new treatments that safely restore normal brain activity in schizophrenia.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Ahrens, Jessica
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~